SUN PHARMA CANADA INC. — Gliclazide Importer Profile
Pharmaceutical Importer · #11 buyer for Gliclazide · $1.4M import value · 61 shipments · CANADA · DGFT Verified
SUN PHARMA CANADA INC. is the #11 importer of Gliclazide from India with $1.4M in import value and 61 verified shipments. SUN PHARMA CANADA INC. holds a 0.4% market share in Gliclazide imports based in CANADA. The company sources from 1 verified supplier across 36 formulations shipped to 1 country. Overall, SUN PHARMA CANADA INC. imports 8 pharmaceutical products worth $8.7M across 5 therapeutic categories.
SUN PHARMA CANADA INC. — Gliclazide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Gliclazide to SUN PHARMA CANADA INC.?
Verified from 61 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.4M | 61 | 100.0% |
SUN PHARMA CANADA INC. sources Gliclazide from 1 verified Indian supplier based on 61 customs records. The primary supplier is SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100.0% of imports.
How Does SUN PHARMA CANADA INC. Compare to Nearest Gliclazide Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | CENTRAL PHARMACEUTICAL JOINT STOCK | VIETNAM | $1.6M | 33 | $50.0K |
| 12 | TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.6M | 58 | $27.9K |
| 11 | SUN PHARMA CANADA INC. ★ | CANADA | $1.4M | 27 | $50.0K |
| 15 | CRESCENT PHARMA LIMITED | UNITED KINGDOM | $1.2M | 54 | $22.2K |
| 1 | MYLAN HUNGARY KFT, | HUNGARY | $1.1M | 21 | $50.0K |
SUN PHARMA CANADA INC. ranks #11 among 643 Gliclazide importers from India. Average shipment value of $50.0K compared to the market average of $40.7K. The closest competitors by value are CENTRAL PHARMACEUTICAL JOINT STOCK and TORRENT DO BRASIL LIMITEDA.
Where Does SUN PHARMA CANADA INC. Import Gliclazide To?
Destination countries from 61 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.4M | 61 | 100.0% |
SUN PHARMA CANADA INC. imports Gliclazide to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.4M.
What Gliclazide Formulations Does SUN PHARMA CANADA INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| GLICLAZIDE MODIFIED RELEASE TABLETS 30MG | $184.1K | 6 |
| HSN CODE:30049099 SAP CODE:1112546 GLICLAZIDE MODIFIED RELEASE TABS 30MG(TARO-GLICLAZIDE MR TAB 30MG)E.MOD.REL.TBS.CONT | $100.0K | 2 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 60MG | $84.1K | 5 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 30MG(TAROGLICLAZIDE MR TAB 30MG) EACH MODIFIED RELEASE TABLET CONTAINS: **** | $67.1K | 3 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 30MG(TARO-GLICLAZIDE MR TABLETS 30MG) (GLICLAZIDE TABLETS 30MG) [38736 PACKS X 100 | $66.9K | 3 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 30MG(TARO-GLICLAZIDE MR TABLETS 30MG) (GLICLAZIDE TABLETS 30MG) [38688 PACKS X 100 | $66.8K | 3 |
| HSN CODE:30049099 SAP CODE:1112547 GLICLAZIDE MODIFIED RELEASE TABS 60MG(TARO-GLICLAZIDE MR TAB 60MG)E.MOD.REL.TBS.CONT | $65.2K | 4 |
| GLICLAZIDE MODIFIED RELEASE TAB 30,TARO | $50.0K | 1 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 60MG(GLICLAZIDE TABLETS 60MG) [2288 PACKS X100'S BOTTLES] BATCH NO. PTE4695A MFG D | $50.0K | 1 |
| GLICLAZIDE MODIFIED RELEASE TABLETS 60MG(GLICLAZIDE TABLETS 60MG) [4692 PACKS X100'S BOTTLES] BATCH NO. PTE4696A & PTE | $50.0K | 1 |
SUN PHARMA CANADA INC. imports 36 distinct Gliclazide formulations from India. The top formulation is GLICLAZIDE MODIFIED RELEASE TABLETS 30MG with 6 shipments worth $184.1K.
Regulatory Requirements: Importing Gliclazide into Canada
What SUN PHARMA CANADA INC. and other importers must comply with to import Gliclazide from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Gliclazide
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Gliclazide from India and How Much Does SUN PHARMA CANADA INC. Import?
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. SUN PHARMA CANADA INC. imports $1.4M of this total, accounting for 0.4% of India's Gliclazide exports with 61 shipments from CANADA. This is verified from 61 customs shipment records covering 36 distinct formulations.
What Is the Average Order Value for SUN PHARMA CANADA INC.'s Gliclazide Imports?
SUN PHARMA CANADA INC.'s average Gliclazide order value is $23.0K per consignment, based on 61 shipments totaling $1.4M. SUN PHARMA CANADA INC. is based in CANADA and ranks #11 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Gliclazide to SUN PHARMA CANADA INC.?
SUN PHARMA CANADA INC. sources Gliclazide from 1 verified Indian supplier: SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.4M, 100.0%). This is based on 61 customs records.
How Does SUN PHARMA CANADA INC. Compare to Other Gliclazide Importers?
SUN PHARMA CANADA INC. ranks #11 among 643 Gliclazide importers from India with a 0.4% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). SUN PHARMA CANADA INC. processed 61 shipments from CANADA.
About SUN PHARMA CANADA INC.
SUN PHARMA CANADA INC. imports 8 products worth $8.7M. Beyond Gliclazide, top products include Esomeprazole, Magnesium, Ramipril, Omeprazole, Sunitinib. View the complete SUN PHARMA CANADA INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SUN PHARMA CANADA INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SUN PHARMA CANADA INC.'s capped import value divided by total capped export value for Gliclazide across all Indian exporters.
- 5.Verified Records: This page is backed by 61 individual customs records matching SUN PHARMA CANADA INC. importing Gliclazide, covering 36 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Import Data for SUN PHARMA CANADA INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for SUN PHARMA CANADA INC.'s Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN PHARMA CANADA INC.
Full Company Profile →
8 products · $8.7M total trade · 5 categories
SUN PHARMA CANADA INC. × Gliclazide
Verified from customs records
Company Overview
Top Products by SUN PHARMA CANADA INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SUN PHARMA CANADA INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.